Retracted: “Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial”

At the request of Sage Publishing and the Executive Editor, the following article has been retracted:

Zheng Y, Dou H, Li Q, Sun Y, Wang Y, Zhang W. Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial. Cancer Control. 2021;28. doi:10.1177/1073274821997444

After an internal investigation Sage became aware that the peer-review process for this article has been compromised and contains indicators of third-party involvement. When we attempted to contact the authors for an explanation, we did not receive a response.

As this was accepted because of a peer-review process that did not meet Sage’s expectations of high quality and ethical peer-review, the publisher cannot uphold the integrity of the research. In line with COPE guidelines and Sage policies, this article has been retracted.

The authors did not respond for comment when notified of this retraction.